Whitehawk Therapeutics, Inc. (WHWK)
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Whitehawk Therapeutics Inc
NASDAQ:WHWKHealthcare · Biotechnology
-1.82%$3.24
AH$3.24+0.00%vs close
Mkt Cap$184.71M
Float39.34M
O/S57.01M
Vol
$ Vol
RVOL
Inst Own75.8%
SI6.7%
Earnings
Dilution
Financials Summary
Revenue$7.14M
Net Income-$20.6M
Total Assets$150.83M
Free Cash Flow-$97.98M
Debt & Equity
Equity 100%
Total Debt$0
Total Equity$136.31M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in WHWK's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$150.83M
Liabilities$14.52M
Accounts Receivable$0
Accounts Payable$917K
Inventory$0
PP&E (Net)$3K
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Revenue | $7.14M | $25.98M | $24.35M | $15.22M | $1.12M | $14.58M | $749K |
| YoY Growth | -72.5% | 6.7% | 60.1% | 1258.6% | -92.3% | 1846.6% | - |
| Cost of Revenue | $760K | $54.05M | $51.74M | $34M | $19.67M | $15.01M | $11.06M |
| Gross Profit | $6.38M | -$28.07M | -$27.38M | -$18.78M | -$18.55M | -$428K | -$10.32M |
| Gross Margin | 89.4% | -108.0% | -112.4% | -123.4% | -1656.3% | -2.9% | -1377.2% |
| Research and Development | $90.96M | $51.03M | $48.93M | $32.66M | $19.67M | $15.01M | $11.06M |
| Selling, General, and Administrative | $29.82M | $36.75M | $44.55M | $40.18M | $18.51M | $2.12M | $1.85M |
| Other | $0 | -$48.39M | -$48.93M | -$28.94M | $54.49M | -$15.01M | -$11.06M |
| Total Operating Expenses | $120.78M | $39.39M | $44.55M | $43.9M | $92.67M | $2.12M | $1.85M |
| Operating Income (EBIT) | -$114.4M | -$67.46M | -$71.93M | -$62.68M | -$111.22M | -$2.55M | -$12.17M |
| Operating Margin | -1601.1% | -259.6% | -295.4% | -411.9% | -9930.1% | -17.5% | -1624.8% |
| Interest Expense | $0 | $154K | $231K | $230K | $665K | $815K | $84K |
| Interest Income | $6.23M | $3.92M | $6.4M | $2.4M | $13K | $41K | $0 |
| Other Income (Expense) | $93.8M | $3.77M | $6.17M | $2.17M | $1.13M | -$927K | -$84K |
| Income Before Tax (EBT) | -$20.6M | -$63.69M | -$65.77M | -$60.51M | -$110.09M | -$3.48M | -$12.25M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $2K | $2K | $1K |
| Net Income | -$20.6M | -$63.69M | -$65.77M | -$60.51M | -$110.09M | -$3.48M | -$12.26M |
| Net Income Margin | -288.3% | -245.1% | -270.0% | -397.7% | -9829.5% | -23.9% | -1636.2% |
| Supplementary Data | |||||||
| EPS | -0.33 | -2.36 | -2.44 | -2.69 | -12.41 | -0.21 | -1.65 |
| Diluted EPS | -0.33 | -2.36 | -2.44 | -2.69 | -12.41 | -0.21 | -1.65 |
| Weighted Average OS | 61.89M | 27.03M | 26.92M | 22.51M | 8.87M | 17.63M | 7.42M |
| EBITDA | -$20.52M | -$64.63M | -$65.36M | -$58.8M | -$36.96M | -$2.54M | -$12.16M |
| EBITDA Margin | -287.2% | -248.7% | -268.4% | -386.4% | -3299.6% | -17.4% | -1624.0% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Assets | |||||||
| Current Assets | |||||||
| Cash and Cash Equivalents | $37.57M | $28.67M | $62.89M | $39.02M | $148.99M | $4.46M | $15.96M |
| Short-Term Investments | $108.13M | $18.57M | $45.96M | $133.54M | $0 | $0 | $0 |
| Cash and Short-Term Investments | $145.7M | $47.24M | $108.84M | $172.56M | $148.99M | $4.46M | $15.96M |
| Accounts Receivable | $0 | $5.9M | $5.49M | $1.86M | $0 | $14.15M | $285K |
| Inventory | $0 | $5.31M | $6.43M | $1.86M | $0 | $0 | $0 |
| Other Current Assets | $3.32M | $0 | $3.83M | $0 | $0 | $0 | $0 |
| Total Current Assets | $149.01M | $61.29M | $124.59M | $180.03M | $151.27M | $18.68M | $16.31M |
| Long-Term Assets | |||||||
| Property, Plant & Equipment Net | $3K | $7.63M | $5.97M | $2.03M | $614K | $140K | $316K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $3.81M | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $1.81M | $1.4M | $1.87M | $2.18M | $2.21M | $0 | $37K |
| Total Long-Term Assets | $1.82M | $9.03M | $7.84M | $4.21M | $6.64M | $140K | $353K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $150.83M | $70.32M | $132.42M | $184.24M | $157.91M | $18.82M | $16.66M |
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts Payable | $917K | $2.16M | $5.9M | $3.52M | $6.44M | $2.39M | $3.18M |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $9.03M | $8.16M |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $3.16M | $64K | $3.08M | $1.57M | $1.47M | $11.61M | $11.85M |
| Total Current Liabilities | $14.52M | $17.07M | $26.39M | $18.84M | $15.27M | $30.06M | $25.62M |
| Long-Term Liabilities | |||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $1.1M | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $202K | $0 | $5.76M | $5.76M | $97K | $0 |
| Total Long-Term Liabilities | $0 | $767K | $833K | $7.02M | $6.23M | $1.2M | $133K |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $14.52M | $17.84M | $27.23M | $25.86M | $21.5M | $31.26M | $25.75M |
| Stockholders' Equity | |||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $1K | $794 |
| Common Stock | $4K | $2K | $2K | $2K | $2K | $1K | $802 |
| Retained Earnings | -$353.25M | -$332.65M | -$268.96M | -$203.2M | -$142.69M | -$32.59M | -$29.12M |
| Comprehensive Income & Other | $120K | $16K | $27K | -$115K | $0 | $0 | $0 |
| Other Stockholders' Equity | $489.56M | $385.13M | $374.16M | $361.57M | $279.09M | $20.16M | $20.02M |
| Total Equity | $136.31M | $52.48M | $105.19M | $158.38M | $136.41M | -$12.43M | -$9.09M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $150.83M | $70.32M | $132.42M | $184.24M | $157.91M | $18.82M | $16.66M |
| Supplementary Data | |||||||
| Total Debt | $0 | $833K | $1.27M | $1.66M | $605K | $10.26M | $8.49M |
| Net Debt | -$37.57M | -$27.84M | -$61.62M | -$37.36M | -$148.38M | $5.8M | -$7.48M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Operating Activities | |||||||
| Net Income | -$20.6M | -$63.69M | -$65.77M | -$60.51M | -$110.09M | -$3.48M | -$12.26M |
| Depreciation & Amortization | $79K | $193K | $169K | $159K | $105K | $9K | $6K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $9.87M | $10.84M | $11.95M | $9.64M | $2.11M | $139K | $106K |
| Changes in Working Capital: | |||||||
| Accounts Receivable | -$1M | -$415K | -$3.63M | -$1.86M | $14.15M | -$13.86M | -$40K |
| Inventory | $170K | $1.12M | -$3.27M | -$1.86M | $0 | $0 | $0 |
| Accounts Payable | $3.92M | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Working Capital | -$1.16M | $3.02M | $3.62M | -$1.32M | -$10.19M | $2.28M | $1.16M |
| Total Working Capital Change | $1.93M | $3.72M | -$3.27M | -$5.04M | $3.96M | -$11.59M | $1.12M |
| Other Non-Cash Items | -$88.72M | -$10.61M | -$2.75M | $6.11M | $81.5M | $2.21M | $3.43M |
| Net Cash from Operating | -$97.43M | -$59.55M | -$59.66M | -$49.64M | -$22.42M | -$12.7M | -$7.58M |
| Investing Activities | |||||||
| Capital Expenditures | -$552K | -$1.65M | -$3.97M | -$444K | -$46K | $0 | -$36K |
| Acquisitions | $101.29M | $0 | $0 | $0 | $25.2M | $0 | $0 |
| Purchases of Investments | -$148.69M | -$36.48M | -$64.44M | -$145.19M | $0 | $0 | $0 |
| Sales of Investments | $59.84M | $63.34M | $151.62M | $12.75M | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | $11.89M | $25.2M | $83.21M | -$132.89M | $25.15M | $0 | -$36K |
| Financing Activities | |||||||
| Debt Repaid | - | - | - | - | - | -$1.19M | -$8.07M |
| Common Stock Issuance | $100M | $130K | $0 | $72.5M | $155M | $0 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | -$4.41M | $0 | $0 |
| Other Financing Activities | -$5.63M | $0 | $326K | $120K | -$8.78M | $0 | $0 |
| Net Cash from Financing | $94.38M | $130K | $326K | $72.62M | $141.8M | $1.19M | $8.07M |
| Forex Effect | $64K | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $8.9M | -$34.22M | $23.87M | -$109.91M | $144.53M | -$11.51M | $15.96M |
| Supplementary Data | |||||||
| Operating Cash Flow | -$97.43M | -$59.55M | -$59.66M | -$49.64M | -$22.42M | -$12.7M | -$7.58M |
| Capital Expenditure | -$552K | -$1.65M | -$3.97M | -$444K | -$46K | $0 | -$36K |
| Free Cash Flow | -$97.98M | -$61.2M | -$63.63M | -$50.08M | -$22.47M | -$12.7M | -$7.62M |
| Cash at Beginning | $28.67M | $62.95M | $39.08M | $148.99M | $4.46M | $15.96M | $0 |
| Cash at End | $37.57M | $28.73M | $62.95M | $39.08M | $148.99M | $4.46M | $15.96M |